Day One Biopharmaceuticals Stock Jumps on Renewed M&A Rumors
Day One Biopharmaceuticals shares surge 26% to $12.62 amid fresh speculation of a potential buyout.
NOTRELOAD AI
Perplexity Chooses CoreWeave to Scale AI Inference, Stock Rises
CoreWeave announces multi-year deal to power Perplexity's AI inference on NVIDIA GB200 clusters.
Abercrombie & Fitch Sees Slower Growth Ahead — Builds 15% U.S. Tariff Impact into 2026 Guidance
Abercrombie & Fitch issued a cautious 2026 outlook, projecting 3–5% sales growth after factoring in the full 15% U.S. tariffs. Shares fell 5% in premarket trading.
SSR Mining Cashes Out: Sells 80% Çöpler Stake to Cengiz for $1.5 Billion
SSR Mining agrees to sell its 80% stake in Turkey's Çöpler gold mine to Cengiz Holding for $1.5B in cash. Deal expected to close Q3 2026; proceeds for reinvestment, shareholder returns, and growth as company shifts focus to Americas.
Can-Fite’s Namodenoson Shows Strong Safety Profile in Advanced Pancreatic Cancer Patients
Can-Fite BioPharma shares positive Phase 2a results for Namodenoson in treating advanced pancreatic cancer, highlighting its safety and potential for better survival outcomes in tough cases.
BW Lands Massive $2.4 Billion AI Data Center Power Contract – Shares Surge
Babcock & Wilcox secures full $2.4B contract to build 1.2GW natural gas power capacity for Applied Digital's AI data centers.